×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Closing Remarks
Speaker(s)
Robert T. Dorsam, PhD
FDA, United States
Associate Director, Pharmacology/Toxicology, Office of Generic Drugs, CDER
Jim Zisek
GlaxoSmithKline, United States
Director, Global CMC Regulatory Affairs
Have an account?